Two Sigma Advisers’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14,000
| Closed | -$26K | – | 2715 |
|
|
2022
Q4 | $26K | Sell |
14,000
-4,300
| -23% | -$8K | ﹤0.01% | 2413 |
|
|
2022
Q3 | $34K | Sell |
18,300
-5,500
| -23% | -$10.2K | ﹤0.01% | 2404 |
|
|
2022
Q2 | $51K | Sell |
23,800
-10,600
| -31% | -$22.7K | ﹤0.01% | 2480 |
|
|
2022
Q1 | $108K | Sell |
34,400
-12,700
| -27% | -$39.9K | ﹤0.01% | 2494 |
|
|
2021
Q4 | $151K | Sell |
47,100
-60,900
| -56% | -$195K | ﹤0.01% | 2357 |
|
|
2021
Q3 | $363K | Sell |
108,000
-224,200
| -67% | -$754K | ﹤0.01% | 2041 |
|
|
2021
Q2 | $1.3M | Buy |
332,200
+12,600
| +4% | +$49.3K | ﹤0.01% | 1516 |
|
|
2021
Q1 | $1.29M | Sell |
319,600
-273,800
| -46% | -$1.1M | ﹤0.01% | 1510 |
|
|
2020
Q4 | $1.37M | Buy |
593,400
+425,200
| +253% | +$982K | ﹤0.01% | 1430 |
|
|
2020
Q3 | $965K | Buy |
+168,200
| New | +$965K | ﹤0.01% | 1513 |
|
|
2020
Q2 | – | Sell |
-23,400
| Closed | -$70K | – | 2577 |
|
|
2020
Q1 | $70K | Buy |
23,400
+4,200
| +22% | +$12.6K | ﹤0.01% | 2348 |
|
|
2019
Q4 | $80K | Buy |
+19,200
| New | +$80K | ﹤0.01% | 2267 |
|